Welcome and opening the Congress

Mr. Hans Brügemann, founder and executive director REGUMED

This is the 51st Congress to be held on the subject of the bioresonance method. The first Congress took place in 1979 on Lake Starnberg. Even back then users were making important suggestions and discoveries which continue to play an important role in developing the method today.

Our Congresses are shaped by broad- mindedness and the common objective of helping many patients by using an advanced, non-invasive form of therapy free from side effects. In particular, the bioresonance method is often able to help restore health to patients with conditions which conventional medicine is unable to treat effectively.

The great willingness of bioresonance therapists to pass on their knowledge and experiences is extremely gratifying and helps us to further develop and underpin our methods. This willingness unites bioresonance users and provides them with a unique set of skills. It also helps to integrate the bioresonance method more firmly into the world of medicine.

Once again, almost 600 participants are attending our Congress this year, including over 200 overseas participants from 24 countries across the globe.

There is an increasing need to provide the authorities with evidence of efficacy for all indications. Which is why we need a wealth of well-documented treatment reports in order to safeguard the future of the bioresonance method. Because bioresonance therapy is not particularly suited to random double-blind studies, its efficacy can best be demonstrated by making a sufficiently large number of well- documented individual case studies available.

It would therefore be of great value to us if a number of therapists were prepared to document cases systematically in order to strengthen the body of evidence available. Guidelines have been drawn up for this purpose. If experiences are documented according to these guidelines the documentation becomes more credible and helps to safeguard the bioresonance method from a legal perspective too.

A huge vote of thanks goes to all speakers at this Congress and for the papers they have produced, which are now available in print in our Congress RTI Volume. I hope that you are able to take plenty of useful suggestions from this year’s Volume to apply in practice, to enable you to provide even more effective patient care. And this in turn will help consolidate the standing of bioresonance therapy.

Hans Brügemann
Director of the Bioresonance Therapy
International Medical Working Group